Skip to main content
Equibles

AWM Investment Company, Inc.

Position in RNA — Atrium Therapeutics, Inc.

CIK 1535264 NEW YORK, NY
Back to RNA Full portfolio

Position in RNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,445,875
+$777,375 QoQ
Shares Held
107,500
+115.0% QoQ
Ownership
0.628%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#39
of 154 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AWM Investment Company, Inc. holds $126,778,855 across 25 Biotechnology names. RNA ranks #19 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DFTX
Definium Therapeutics, Inc.
 784,800 $36,916,992
2 FENC
Fennec Pharmaceuticals Inc.
 1,160,296 $12,473,182
3 ACOG
Alpha Cognition Inc.
 1,672,168 $12,073,052
4 PVLA
Palvella Therapeutics, Inc.
 69,416 $10,608,153
5 ABEO
Abeona Therapeutics Inc.
 1,486,130 $9,184,283
6 RANI
Rani Therapeutics Holdings, Inc.
 7,500,000 $5,700,000
7
222,500 $4,728,125
8 ELDN
Eledon Pharmaceuticals, Inc.
 1,100,000 $4,334,000

All Filings in RNA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,445,875 107,500
2026-03-31 $668,500 50,000